---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-059479"
form_type: "8-K"
ticker: "HRTX"
cik: "0000818033"
company_name: "HERON THERAPEUTICS, INC. /DE/"
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T04:28:09.720476+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Heron Therapeutics appoints Mark Hensley as COO effective April 28, 2025

## Summary
- Annual base salary of $553,000; target cash bonus of $276,500 (50% of base), prorated for 2025.
- Inducement awards: option for 500K shares, 500K RSUs, and performance option for up to 900K shares.
- Vesting: option and RSUs vest over 4 years; performance option vests upon stock price goals.
- Hensley previously served as CEO of Veloxis Pharmaceuticals from 2021 to 2024.
- Awards granted outside 2007 Plan as material inducement under Nasdaq Rule 5635(c)(4).

## SEC filing metadata
- accession: 0000950170-25-059479
- form_type: 8-K
- ticker: HRTX
- cik: 0000818033
- company_name: HERON THERAPEUTICS, INC. /DE/
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818033/000095017025059479/0000950170-25-059479-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818033/000095017025059479/hrtx-20250428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-059479
- JSON: https://secwatch.observer/filing/0000950170-25-059479.json
- Plain text: https://secwatch.observer/filing/0000950170-25-059479.txt

## Key facts
- Executive change
  Mark Hensley was appointed as Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On April 28, 2025, Heron Therapeutics, Inc. (the “ Company ”) announced that it appointed Mark Hensley as Chief Operating Officer, effective April 28, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/818033/000095017025059479/0000950170-25-059479-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.